Abstract The global HIV pandemic began to expand rapidly in southern Africa a decade later than was noted in central Africa, Europe, the Caribbean, and North America. Multiple factors played a role in this rapid expansion which led Southern Africa to become the most heavily afflicted region for HIV/AIDS globally. In this issue of Current HIV/AIDS Reports, investigators with active research interests in the region have reviewed key elements of the causes of and responses to the epidemic. Putative causes of the high HIV prevalence in the region are discussed, including host and viral biology, human behavior, politics and policy, structural factors, health services, health workforce, migration, traditional healers' role, and other issues. Regional epidemiological trends are described and forecasted. Issues related to the continuum of HIV care and treatment are highlighted. We hope that the reviews will prove useful to those policymakers, health care workers, and scientists who are striving to reduce the burden of HIV in the southern African region, as well as prove insightful for key issues of broader global relevance.
Introduction
Work from Kwazulu-Natal published in 2011 described agestratified trends in HIV prevalence for pregnant women in antenatal care [1] . The numbers rose with time such that nearly two thirds of the women ages 25-29 in 2004 were infected with HIV (Table 1) . Tuberculosis was similarly on the rise largely due to the concurrent HIV epidemic. Hence, the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the President's Emergency Plan for AIDS Relief (PEPFAR), and the Global Fund to Fight AIDS, Tuberculosis and Malaria all highlight southern Africa as the region with highest priority for interventions. (For the purpose of discussion, southern Africa includes the following: Angola, Botswana, Lesotho, Malawi, Namibia, Mozambique, South Africa, Swaziland, Zambia, and Zimbabwe. However, Angola is not emphasized given its more modest, though now growing, epidemic to date.) While incidence rates in the past decade are trending downwards for women attending antenatal care (a valuable sentinel population for assessing both risk for adults and children), these incidence rates remain the highest in the world.
Within this issue of Current HIV/AIDS Reports, Williams et al. take available data for key southern African nations, projecting future trends in incidence, prevalence, mortality, coverage of antiretroviral therapy (ART), and tuberculosis (TB) notification rates based on plausible assumptions and mathematical models [2•]. Simelela et al. present a historical view of the policy and political response to the epidemic in South Africa, including the community activism that turned This article is part of the Topical Collection on The Global Epidemic the tide of inaction among Africa's largest and most aggressive HIV programs (Fig. 1) [3•] . While progress is being made in strengthening health systems to take on HIV services, some nations in the region are much better capacitated than others, creating uncertainty regarding the sustainability of interventions and hence long-lasting success in the epidemic response [4] . BoltonMoore and Ciaraldi tackle the health systems issues that underscore these health disparities and highlight areas of ongoing need and improvement [5•] . Bhardwaj et al. do the same with the focus on issues specifically related to mothers, neonates, and children, an area of considerable progress in South Africa, for example ( Fig. 1 ), but less so in Mozambique [6•, 7, 8] .
Why the Southern African Epidemic is Severe
Several articles in this issue of Current HIV/AIDS Reports address the putative causes for the high HIV incidence and prevalence in the southern African region. Kaul et al. highlight the role of genital and systemic inflammation in increasing risk of sexual acquisition of HIV [9•] . His immunological focus presents numerous opportunities for intervention in the vaginal microbiome and systemic immune system. To review virologic factors that may be relevant in the subtype C dominant southern African context, we refer readers to data and debates elsewhere [10] [11] [12] [13] .
Both 
The Continuum of Care
Many of the authors of this issue address the need to expand testing, linkage to care, retention issues, and adherence to ART. Audet et al. explain that while successful program expansion requires a radical expansion in the health workforce, this has not happened accordingly with the need [15•, 16, 17] . Continual nursing and physician Bbrain drain^from Africa to high income nations such as the USA and the UK has not been addressed successfully [18] [19] [20] . In addition, internal brain drain from urban to rural areas, and from the public to private sector, is another phenomenon that has not merited enough attention. These are contributing factors to the scarcity of the health workforce in the highest need areas in southern Africa [21] . To overcome the lack of qualified workforce, many countries have implemented task-shifting programs and adopted training of other type of cadres, such as community health care workers, with increasing responsibilities [22] . Hence, more effective partnerships between close-to-community health care workers (community health workers, traditional birth attendants, etc.) and traditional healers must be considered to facilitate referrals and establish a strong system of support for treatment adherence and other HIV care-related issues [15•, 23, 24] . As providers and governments move toward expanded service and scale, retention in care proves to be one of the most important components. Audet et al. state that while there have been successful efforts to increase referrals from traditional practitioners to allopathic care, buy-in from the health care workers themselves, who are deeply skeptical of traditional healers, is critical for fruitful collaboration. [5•] . This would ideally be in an integrated care system approach, which would also serve to expand care for a myriad of neglected non-communicable diseases [26, 27] . TasP has increased focus on the need to provide access to medications in a timely manner without treatment interruption due to drug stockouts, expand services to enhance access to testing and retention in care, and improved attention to highly vulnerable key populations, including adolescent and young women, persons in serodiscordant relationships, men who have sex with men (MSM), sex workers, and people who inject drugs (PWID) [23] . insight on a country-by-country basis on the substantial progress to date, but also the daunting needs of what will be necessary to meet target goals. In aggregate, the articles in this issue provide a valuable snapshot as to the urgency of staying the course in HIV control and prevention, including the expansion of ART access and tuberculosis control efforts. Only one third of the global HIV treatment need has been met, and gigantic challenges persist, such as imperfect implementation of the care cascade, with often low retention and adherence to treatment leading to inadequate viral suppression, with all subsequent consequences at the individual patient level. Challenges also include the broader public health level, including efforts for prevention and control of HIV. BDonor fatigue^that seems to be emerging and affecting needed expansion of interventions and resources, including from PEPFAR and the Global Fund, may result in a reversal of gains and an uptick in incidence after a decade of considerable successful progress [32, 33] . Concerted efforts and high commitment from all, including funding partners, policymakers, researchers, and implementers, are required to maintain or even enhance the inspiring gains made to date [34] [35] [36] [37] [38] .
